Cargando…

TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4

Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiang, Shao, Yijia, Tu, Jiazichao, Sun, Jiapan, Dong, Bing, Wang, Zhichao, Zhou, Jianrong, Chen, Long, Tao, Jun, Chen, Jimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841965/
https://www.ncbi.nlm.nih.gov/pubmed/35174166
http://dx.doi.org/10.3389/fcell.2021.804049
_version_ 1784650956283052032
author Liu, Xiang
Shao, Yijia
Tu, Jiazichao
Sun, Jiapan
Dong, Bing
Wang, Zhichao
Zhou, Jianrong
Chen, Long
Tao, Jun
Chen, Jimei
author_facet Liu, Xiang
Shao, Yijia
Tu, Jiazichao
Sun, Jiapan
Dong, Bing
Wang, Zhichao
Zhou, Jianrong
Chen, Long
Tao, Jun
Chen, Jimei
author_sort Liu, Xiang
collection PubMed
description Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of miRNAs compared to those from the TMAO-free group (Control-Exos). Furthermore, TMAO-Exos could notably promote inflammation, damage vascular endothelial cells (VECs), and impair endothelium-dependent vasodilation. This study aimed to further evaluate the effects of TMAO-Exos on VECs and explore the underlying mechanisms. Methods: Exos were isolated from the hepatocyte culture supernatant with or without TMAO, using differential centrifugation. Then, VECs were treated with these Exos for 48 h and subjected to RNA-sequencing for detecting the changes of alternative polyadenylation (APA) and mRNA. After validation by qPCR and western blotting, the recombinant viruses were used to mediate the overexpression of C-X-C motif chemokine receptor 4 (CXCR4). The in vitro VEC function was evaluated by cell migration and tube formation, and in vivo angiogenesis was investigated in hindlimb ischemia models. Results: Exos released from hepatocytes were differentially regulated by TMAO; both could be taken up by VECs; and furthermore, TMAO-Exos significantly reduced cell migration and tube formation in vitro and impaired perfusion recovery and angiogenesis after hindlimb ischemia, by down-regulating the CXCR4 expression. However, TMAO-Exos failed to regulate the splicing events, at least in this experimental setting, which suggested that TMAO-Exos may affect CXCR4 expression via an APA-independent manner. Conclusions: Our findings revealed a novel indirect mechanism by which TMAO impaired endothelial function through stimulating hepatocytes to produce Exos that possessed distinctive activity. The crosstalk between the liver and vascular endothelial mediated by these Exos may offer a new target for restraining the harmful effects induced by TMAO.
format Online
Article
Text
id pubmed-8841965
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88419652022-02-15 TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4 Liu, Xiang Shao, Yijia Tu, Jiazichao Sun, Jiapan Dong, Bing Wang, Zhichao Zhou, Jianrong Chen, Long Tao, Jun Chen, Jimei Front Cell Dev Biol Cell and Developmental Biology Objective: Trimethylamine-N-oxide (TMAO) was found to play crucial roles in vascular endothelial function. However, the exact molecular mechanisms are not yet entirely clear. Recently, we found that exosomes (Exos) isolated from TMAO-treated hepatocytes (TMAO-Exos) contained a distinctive profile of miRNAs compared to those from the TMAO-free group (Control-Exos). Furthermore, TMAO-Exos could notably promote inflammation, damage vascular endothelial cells (VECs), and impair endothelium-dependent vasodilation. This study aimed to further evaluate the effects of TMAO-Exos on VECs and explore the underlying mechanisms. Methods: Exos were isolated from the hepatocyte culture supernatant with or without TMAO, using differential centrifugation. Then, VECs were treated with these Exos for 48 h and subjected to RNA-sequencing for detecting the changes of alternative polyadenylation (APA) and mRNA. After validation by qPCR and western blotting, the recombinant viruses were used to mediate the overexpression of C-X-C motif chemokine receptor 4 (CXCR4). The in vitro VEC function was evaluated by cell migration and tube formation, and in vivo angiogenesis was investigated in hindlimb ischemia models. Results: Exos released from hepatocytes were differentially regulated by TMAO; both could be taken up by VECs; and furthermore, TMAO-Exos significantly reduced cell migration and tube formation in vitro and impaired perfusion recovery and angiogenesis after hindlimb ischemia, by down-regulating the CXCR4 expression. However, TMAO-Exos failed to regulate the splicing events, at least in this experimental setting, which suggested that TMAO-Exos may affect CXCR4 expression via an APA-independent manner. Conclusions: Our findings revealed a novel indirect mechanism by which TMAO impaired endothelial function through stimulating hepatocytes to produce Exos that possessed distinctive activity. The crosstalk between the liver and vascular endothelial mediated by these Exos may offer a new target for restraining the harmful effects induced by TMAO. Frontiers Media S.A. 2022-01-31 /pmc/articles/PMC8841965/ /pubmed/35174166 http://dx.doi.org/10.3389/fcell.2021.804049 Text en Copyright © 2022 Liu, Shao, Tu, Sun, Dong, Wang, Zhou, Chen, Tao and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Liu, Xiang
Shao, Yijia
Tu, Jiazichao
Sun, Jiapan
Dong, Bing
Wang, Zhichao
Zhou, Jianrong
Chen, Long
Tao, Jun
Chen, Jimei
TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title_full TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title_fullStr TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title_full_unstemmed TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title_short TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4
title_sort tmao-activated hepatocyte-derived exosomes impair angiogenesis via repressing cxcr4
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841965/
https://www.ncbi.nlm.nih.gov/pubmed/35174166
http://dx.doi.org/10.3389/fcell.2021.804049
work_keys_str_mv AT liuxiang tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT shaoyijia tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT tujiazichao tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT sunjiapan tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT dongbing tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT wangzhichao tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT zhoujianrong tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT chenlong tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT taojun tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4
AT chenjimei tmaoactivatedhepatocytederivedexosomesimpairangiogenesisviarepressingcxcr4